Literature DB >> 26776554

Systematic analysis of ECG predictors of sinus rhythm maintenance after electrical cardioversion for persistent atrial fibrillation.

Theo Lankveld1, Cees B de Vos2, Ione Limantoro2, Stef Zeemering3, Elton Dudink2, Harry J Crijns2, Ulrich Schotten4.   

Abstract

BACKGROUND: Electrical cardioversion (ECV) is one of the rhythm control strategies in patients with persistent atrial fibrillation (AF). Unfortunately, recurrences of AF are common after ECV, which significantly limits the practical benefit of this treatment in patients with AF.
OBJECTIVES: The objectives of this study were to identify noninvasive complexity or frequency parameters obtained from the surface electrocardiogram (ECG) to predict sinus rhythm (SR) maintenance after ECV and to compare these ECG parameters with clinical predictors.
METHODS: We studied a wide variety of ECG-derived time- and frequency-domain AF complexity parameters in a prospective cohort of 502 patients with persistent AF referred for ECV.
RESULTS: During 1-year follow-up, 161 patients (32%) maintained SR. The best clinical predictor of SR maintenance was antiarrhythmic drug (AAD) treatment. A model including clinical parameters predicted SR maintenance with a mean cross-validated area under the receiver operating characteristic curve (AUC) of 0.62 ± 0.05. The best single ECG parameter was the dominant frequency (DF) on lead V6. Combining several ECG parameters predicted SR maintenance with a mean AUC of 0.64 ± 0.06. Combining clinical and ECG parameters improved prediction to a mean AUC of 0.67 ± 0.05. Although the DF was affected by AAD treatment, excluding patients taking AADs did not significantly lower the predictive performance captured by the ECG.
CONCLUSION: ECG-derived parameters predict SR maintenance during 1-year follow-up after ECV at least as good as known clinical predictors of rhythm outcome. The DF proved to be the most powerful ECG-derived predictor.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Electrical cardioversion; Electrocardiography

Mesh:

Substances:

Year:  2016        PMID: 26776554     DOI: 10.1016/j.hrthm.2016.01.004

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  6 in total

1.  Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices.

Authors:  José María Lillo-Castellano; Juan José González-Ferrer; Manuel Marina-Breysse; José Bautista Martínez-Ferrer; Luisa Pérez-Álvarez; Javier Alzueta; Juan Gabriel Martínez; Aníbal Rodríguez; Juan Carlos Rodríguez-Pérez; Ignasi Anguera; Xavier Viñolas; Arcadio García-Alberola; Jorge G Quintanilla; José Manuel Alfonso-Almazán; Javier García; Luis Borrego; Victoria Cañadas-Godoy; Nicasio Pérez-Castellano; Julián Pérez-Villacastín; Javier Jiménez-Díaz; José Jalife; David Filgueiras-Rama
Journal:  Europace       Date:  2020-05-01       Impact factor: 5.214

2.  Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?

Authors:  Nicklas Vinter; Anne Sofie Frederiksen; Andi Eie Albertsen; Gregory Y H Lip; Morten Fenger-Grøn; Ludovic Trinquart; Lars Frost; Dorthe Svenstrup Møller
Journal:  Open Heart       Date:  2020-06

3.  Noninvasive Assessment of Atrial Fibrillation Complexity in Relation to Ablation Characteristics and Outcome.

Authors:  Marianna Meo; Thomas Pambrun; Nicolas Derval; Carole Dumas-Pomier; Stéphane Puyo; Josselin Duchâteau; Pierre Jaïs; Mélèze Hocini; Michel Haïssaguerre; Rémi Dubois
Journal:  Front Physiol       Date:  2018-07-17       Impact factor: 4.566

4.  Multi-scale Entropy Evaluates the Proarrhythmic Condition of Persistent Atrial Fibrillation Patients Predicting Early Failure of Electrical Cardioversion.

Authors:  Eva María Cirugeda Roldan; Sofía Calero; Víctor Manuel Hidalgo; José Enero; José Joaquín Rieta; Raúl Alcaraz
Journal:  Entropy (Basel)       Date:  2020-07-07       Impact factor: 2.524

5.  In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria.

Authors:  Albert Dasí; Aditi Roy; Rafael Sachetto; Julia Camps; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Front Physiol       Date:  2022-09-15       Impact factor: 4.755

6.  The efficacy and safety of amiodarone combined with beta-blockers in the maintenance of sinus rhythm for atrial fibrillation: A protocol for systematic review and network meta-analysis.

Authors:  Shuqing Shi; Qiulei Jia; Jingjing Shi; Shuai Shi; Guozhen Yuan; Yuanhui Hu
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.